LiVDerm provides practicing clinicians with innovative and integrated education across the dermatology ecosystem.
LiVDerm is a leading medical education hub dedicated to revolutionizing dermatology education. Through our mission to boldly advance higher standards of dermatology care, LiVDerm has emerged as a leading educational source for the latest therapies, technologies, procedures, and practice guidelines in medical and aesthetic medicine. With a multi-pronged focus on the myriad specialties within the de
08/25/2026
✨ 2027 marks 25 years of the South Beach Symposium—25 years of education, innovation, and connection within the dermatology community.
🎉 Take 25% off both South Beach Symposium (SBS) and Masters of Pediatric Dermatology (MOPD) symposium registration using code: CELEBRATE25
Register today 🔗 https://bit.ly/4cupJfh
Dr. Christopher Bunick and Dr. Joel Claveau discuss Moderna and Merck's positive Phase 3 results for mRNA-based therapy in surgically resected melanoma patients.
Dr. Claveau calls it "a big change of paradigm in the treatment of cancer" and "great news for our patients."
The therapy aims to prevent melanoma recurrence following surgical resection, building on promising Phase 2 trial data.
08/20/2026
🔬 Breakthrough in melanoma treatment!
Merck and Moderna announced positive Phase 3 INTerpath-001 trial results for personalized mRNA therapy intismeran combined with pembrolizumab in patients with completely resected stage IIB-IV melanoma.
This personalized vaccine is tailored to each patient's tumor, encoding up to 34 neoantigens to train the immune system to target cancer cells. It marks the first positive Phase 3 readout for an individualized neoantigen therapy in adjuvant melanoma.
📖 Read the full article here: https://go.livderm.org/4c1upZP
08/17/2026
Pediatric dermatology is complex—treating children requires specialized knowledge, tailored approaches, and strong family communication.
Our latest blog explores the fundamentals of pediatric dermatology and the emerging therapies improving outcomes for young patients.
Read now 🔗 https://go.livderm.org/4ziPEjP
08/12/2026
🎉 Celebrating 35 years of Masters of Pediatric Dermatology!
For over three decades, MOPD has been the trusted forum where clinicians, experts, and educators come together to advance care for children with dermatologic conditions.
From groundbreaking discoveries to meaningful collaboration, this community continues to shape the future of pediatric dermatology.
🎇 Ready to be part of the legacy?
Register now for MOPD 🔗 https://go.livderm.org/4wXM1hm
08/05/2026
The management of chronic spontaneous urticaria (CSU) is evolving fast—with new BTK inhibitors and anti-IL-4Rα biologic therapies changing the treatment landscape.
Join Dr. Christopher G. Bunick, MD, PhD in this on-demand CME activity recorded at the 2026 South Beach Symposium.
What you'll learn:
✔️ Chronic urticaria overview and differential diagnosis
✔️ Current CSU management recommendations
✔️ FDA-approved second-line therapies and emerging agents
Earn 0.50 CME credits while staying current on the latest evidence-based approaches.
🔗 Start the activity now: https://bit.ly/4bvhOOd
Supported by an educational grant from Novartis Pharmaceuticals Corporation.
08/04/2026
This August is Psoriasis Awareness Month—a time to recognize the complex impact this condition has on patients' quality of life, emotional well-being, and overall health.
Explore LiVDerm's Psoriasis Digital Education Hub for curated CME activities, expert insights, and clinical resources on emerging therapies and strategies for managing disease burden.
👉 Learn more: https://bit.ly/4vYTYl7
08/01/2026
August is Psoriasis Awareness Month, making it an ideal time to examine the links between psoriasis and obesity.
Shared inflammatory and metabolic pathways create a bidirectional relationship between the chronic skin disease and obesity, and implementing a comprehensive care plan that addresses both conditions can be a crucial step toward improving patient outcomes.
Learn more about the connections between psoriasis and obesity, and how addressing both conditions together may reduce disease burden and improve quality of life.
🔗 Read the full blog at the link in our bio!